A population pharmacokinetic model of epidural lidocaine in geriatric patients: Effects of low-dose dopamine

Therapeutic Drug Monitoring

Volumn 30, Issue 3, 2008, Pages 379-389

  Kwa, Andrea ^a   Sprung, Juraj ^b   Guilder, Michael Van ^c   Jelliffe, Roger W ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anesthesia; Epidural lidocaine; Lidocaine; Population modeling

Indexed keywords

DOPAMINE; LIDOCAINE; PLACEBO; SODIUM CHLORIDE; LOCAL ANESTHETIC AGENT;

AGED; ANALYTICAL ERROR; ARTICLE; BLOOD LEVEL; CALCULATION; CEREBROSPINAL FLUID; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG ELIMINATION; DRUG INFUSION; EPIDURAL SPACE; GAS CHROMATOGRAPHY; GERIATRIC PATIENT; HUMAN; KINETICS; LOCAL ANESTHESIA; LOW DRUG DOSE; MALE; MODEL; PARAMETER; POPULATION; PRIORITY JOURNAL; SAMPLE; SERUM; TISSUE PERFUSION; VASCULAR SURGERY; WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG INTERACTION; EPIDURAL ANESTHESIA; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

AGED; ANESTHESIA, EPIDURAL; ANESTHETICS, LOCAL; DOPAMINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HUMANS; LIDOCAINE; LINEAR MODELS; MODELS, STATISTICAL; POPULATION;

EID: 47249124819     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181778fa3     Document Type: Article

References (37)

1. Yeager MP, Glass DD, Neff RK, et al. Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology. 1987;66:729-736.
2. Cousins MJ, Wright CJ. Graft, muscle, skin blood flow after epidural block in vascular surgical procedures. Surg Gynecol Obstet. 1971;133: 59-64.
3. Christopherson R, Beattie C, Frank SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993;79:422-434.
4. Lalka D, Griffith RK, Cronenberger CL. The hepatic first-pass metabolism of problematic drugs. J Clin Pharmacol. 1993;33:657-669.
5. Sprung J, Bourke DL, Schoenwald PK, et al. Small-dose dopamine increases epidural lidocaine requirements during peripheral vascular surgery in elderly patients. Anesth Analg. 2000;90:388-392.
6. Ochs HR, Carstens G, Greenblatt DJ. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med. 1980;303:373-377.
7. Branch RA, Shand DG, Wilkinson GR, et al. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. J Pharmacol Exp Ther. 1973;184:515-519.
8. Tanaka N, Nagata N, Hamakawa T, et al. The effect of dopamine on hepatic blood flow in patients undergoing epidural anesthesia. Anesth Analg. 1997;85:286-290.
9. Shimadzu K, Nishi S, Kariya N, et al. The pharmacokinetic change of lidocaine by catecholamines using isolated perfused rat liver (IPRL). Life Sci. 1998;62:2399-2405.
10. RxMed web site, pharmaceutical information as of 8/14/06 - Xylocaine. Available at: www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/ CPS-%20Monographs/CPS-%20(General%20Monographs-%20X)/XYLOCAINE. html. Accessed 2006.
11. Rodman J, Jelliffe R, Kolb E, et al. Clinical studies with computer-assisted initial lidocaine therapy. Arch Intern Med. 1984;144:703-709.
12. Jelliffe R, Schumitzky A, Van Guider M, et al. User manual for version 10.7 of the USC*Pack collection of PC programs, Laboratory of Applied Pharmacokinetics. Los Angeles: University of Southern California School of Medicine; 1995.
13. Schumitzky A. Nonparametric EM algorithms for estimating prior distributions. Appl Math Computation. 1991;45:143-157.
14. Leary R, Jelliffe R, Schumitzky A, et al. A Unified Parametric/ Nonparametric Approach to Population PK/PD Modeling. Presented at the Annual Meeting of the Population Approach Group in Europe, Paris, France, June 6-7, 2002.
15. Bustad A, Terziivanov D, Leary R, et al. Parametric and nonparametric population methods: their comparative performance in analysing a clinical data set and two Monte Carlo simulation studies. Clin Pharmacokinet. 2006;45:365-383.
16. De Groot M. Probability and Statistics, 2nd ed. Reading, MA: Addison-Wesley; 1989:496-498.
17. Burm A. Clinical pharmacokinetics of epidural and spinal anesthesia. Clin Pharmacokinet. 1989;16:283-311.
18. Downing J, Johnson V, Gonzalez H, et al. The pharmacokinetics of epidural lidocaine and bupivacaine during cesarean section. Anesth Analg. 1997;84:527-532.
19. Doherty M, Hughes P, Charman S, et al. Biphasic absorption from the epidural space of the dog may limit the utility of a slow release medium molecular weight hyaluronic acid-lidocaine ionic complex formation. Anesth Analg. 1996;83:1244-1250.
20. Blaschke TF, Rubin PC. Hepatic first-pass metabolism in liver disease. Clin Pharmacokinet. 1979;4:423-432.
21. Bauer LA, Brown T, Gibaldi M, et al. Influence of long-term infusions on lidocaine kinetics. Clin Pharmacol Ther. 1982;31:433-437.
22. Prescott LF, Adjepon-Yamoah KK, Talbot RG. Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. BMJ. 1976;1:939-941.
23. Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet. 1978;3:177-201.
24. Abernethy DR, Greenblatt DJ. Impairment of lidocaine clearance in elderly male subjects. J Cardiovasc Pharmacol. 1983;5:1093-1096.
25. Brandfonbrener M, Landowne M, Shock N. Changes in cardiac output with age. Circulation. 1955;27:557-566.
26. Bowdle TA, Freund PR, Slattery JT. Propranolol reduces bupivacaine clearance. Anesthesiology. 1987;66:36-38.
27. Arndt JO, Hock A, Stanton-Hicks M, et al. Peridural anesthesia and the distribution of blood in supine humans. Anesthesiology. 1985;63: 616-623.
28. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1995:199-248.
29. Sasyniuk BI, Ogilvie RI. Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations. Annu Rev Pharmacol. 1975;15: 131-155.
30. LeLorier J, Grenon D, Latour Y, et al. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med. 1977;87:700-706.
31. Winso O, Biber B, Fornander J, et al. Effects of dopamine on the portal circulation after therapeutic hepatic artery ligation. Acta Anaesthesiol Scand. 1988;32:458-463.
32. Burm A, Vermeulen N, van Kleef J, et al. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet. 1987;13:191-203.
33. Lund P, Cwik J. Citanest: a clinical and laboratory study. Anesth Analg. 1965;44:623-631.
34. Lund P, Covino B. Distribution of local anesthetics in man following peridural anesthesia. J Clin Pharmacol. 1967;7:324-329.
35. Bayard D, Jelliffe RW, Schumitzky A, et al. Precision drug dosage regimens using multiple model adaptive control: theory, and application to stimulated vancomycin therapy. In: Rao KS, Sridhar R, eds. Vasudevan Memorial Volume on Theoretical Physics, Stochastic Processes, and Biological Sciences. Madras, India: Allied Publishers Ltd; 1995:407-426.
36. Jelliffe R, Schumitzky A, Bayard D, et al. Model-based, goal-oriented, individualized drug therapy: linkage of population modeling, new 'multiple model' dosage design, Bayesian feedback, and individualized target goals. Clin Pharmacokinet. 1998;34:57-77.
37. Jelliffe R, Bayard D, Milman M, et al. Achieving target goals most precisely using nonparametric compartmental models and 'multiple model' design of dosage regimens. Ther Drug Monit. 2000;22:346-353.